No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Bleomycin / administration & dosage
-
Boronic Acids / administration & dosage
-
Bortezomib
-
Combined Modality Therapy
-
Dacarbazine / administration & dosage
-
Dexamethasone / administration & dosage
-
Doxorubicin / administration & dosage
-
Epstein-Barr Virus Infections / pathology
-
Epstein-Barr Virus Infections / virology
-
Hematopoietic Stem Cell Transplantation
-
Hodgkin Disease / diagnosis*
-
Hodgkin Disease / pathology
-
Hodgkin Disease / virology
-
Humans
-
Lenalidomide
-
Male
-
Middle Aged
-
Multiple Myeloma / drug therapy*
-
Multiple Myeloma / surgery
-
Neoplasms, Second Primary / diagnosis*
-
Neoplasms, Second Primary / pathology
-
Neoplasms, Second Primary / virology
-
Pyrazines / administration & dosage
-
Salvage Therapy
-
Thalidomide / administration & dosage
-
Thalidomide / analogs & derivatives
-
Transplantation Conditioning / adverse effects
-
Transplantation, Autologous
-
Vinblastine / administration & dosage
-
Vincristine / administration & dosage
Substances
-
Boronic Acids
-
Pyrazines
-
Bleomycin
-
Thalidomide
-
Vincristine
-
Vinblastine
-
Bortezomib
-
Dacarbazine
-
Dexamethasone
-
Doxorubicin
-
Lenalidomide
Supplementary concepts
-
ABVD protocol
-
VAD protocol